Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Navigating the technology maze.

Miller1

  • 1Applied Biosystems Division, PE Biosystems, 850 Lincoln Center Drive, Foster City, CA 94404-1128, USA.

Drug Discovery Today
|June 17, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rovibronic Spectroscopy of MgCH3 Ã2E <-- &Xtilde;2A1 Transition.

Journal of molecular spectroscopy·1999
Same author

Glycosylation of CHO-derived recombinant tPA produced under elevated pCO2

Biotechnology progress·1999
Same author

Rapid reduction of Hg(II) by mercuric ion reductase does not require the conserved C-terminal cysteine pair using HgBr2 as the substrate

Biochemistry·1999
Same author

Spontaneous Emulsification of Oils Containing Hydrocarbon, Nonionic Surfactant, and Oleyl Alcohol.

Journal of colloid and interface science·1999
Same author

Pleistocene extinction of genyornis newtoni: human impact on australian megafauna

Science (New York, N.Y.)·1999
Same author

Geographical variation in male courtship behaviour and sexual isolation in wolf spiders of the genus Schizocosa.

Animal behaviour·1998
Same journal

Inorganic nanoparticles for diagnostics, drug delivery and therapy for solid tumors.

Drug discovery today·2026
Same journal

HDAC11 as a potential therapeutic target for Alzheimer's disease.

Drug discovery today·2026
Same journal

From biologics to small-molecule modulators: The evolving landscape of interleukin-targeted therapeutics.

Drug discovery today·2026
Same journal

Targeting the GLP-1 receptor pathways for dual management of obesity and depression.

Drug discovery today·2026
Same journal

Chemical intervention strategies targeting MYC for cancer therapy.

Drug discovery today·2026
Same journal

How many protein pairs can we chemically target?

Drug discovery today·2026
See all related articles

Identifying and evaluating new technologies presents complex challenges for pharmaceutical companies. Strategic decision-making is crucial for successful technology adoption and innovation in the pharma sector.

Area of Science:

  • Pharmaceutical industry
  • Technology management
  • Innovation studies

Background:

  • The pharmaceutical sector relies heavily on technological advancements for drug discovery, development, and manufacturing.
  • Rapid technological evolution necessitates robust frameworks for evaluating and selecting new innovations.

Purpose of the Study:

  • To explore the complexities and critical factors involved in technology identification, evaluation, and selection within pharmaceutical companies.
  • To provide insights into strategic decision-making processes for adopting new technologies.

Main Methods:

  • Qualitative analysis of industry practices.
  • Review of decision-making models in technology management.
  • Case study approach examining pharmaceutical technology adoption.

Related Experiment Videos

Main Results:

  • Technology selection is influenced by strategic alignment, R&D pipeline needs, and market potential.
  • Risk assessment and return on investment (ROI) are key evaluation criteria.
  • Cross-functional collaboration is vital for effective technology evaluation.

Conclusions:

  • Pharmaceutical companies require structured approaches to navigate the complexities of new technology adoption.
  • Effective technology selection strategies can enhance innovation, competitiveness, and therapeutic advancements.